Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,518.00    -32.00 (-2.06%)
Bid:
1,516.00
Ask:
1,520.00
Spread: 4.00 (0.264%)
Market Cap: £791.85m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Acquisition

16 Apr 2025 11:00

RNS Number : 2993F
M. P. Evans Group PLC
16 April 2025
 

M. P. EVANS GROUP PLC

("THE GROUP") ACQUISITION OF ADDITIONAL 2,750 PLANTED HECTARES

M.P. Evans Group PLC, a producer of sustainable Indonesian palm oil, is pleased to announce that its wholly owned subsidiary, PT Evans Indonesia, has signed a conditional share purchase agreement to acquire the entire issued share capital of two Indonesian plantation companies, PT Setara Kilau Mas Adicita ("SKMA") and PT Sumber Bumi Serasi ("SBS"). Their two respective plantations are located close to the Group's Bumi Mas estate and mill. Gross consideration is expected to be approximately US$34.2 million, funded from existing resources, plus a final adjustment to allow for other assets and liabilities on completion and is subject to the finalisation of certain legal, regulatory and other formalities in Indonesia, with completion likely to take place in the third quarter of 2025.

The acquisition is entirely in line with the Group's stated strategy to add further planted hectarage close to its existing operations. SKMA and SBS both own oil-palm plantations in East Kalimantan, with a total planted hectarage of 2,750 hectares under direct ownership and a further 250 hectares managed on behalf of associated smallholder co-operatives. The total crop from the areas being acquired was 50,300 tonnes in the year to 30 June 2024. Those areas are relatively young, having all been planted since 2016, and so the Group expects yields to increase in future years. Following completion of the acquisition, SKMA and SBS will be managed as part of the Bumi Mas estate, and all the crop from both acquired properties will be sent for processing in the Bumi Mas mill.

The Group is acquiring SKMA and SBS from PT Golden Land Gemilang, which is a wholly owned subsidiary of Golden Land Berhad, a listed Malaysian company with subsidiaries in the Indonesian oil-palm sector, as well as from Jeffrey Lachmandas Mahtani and Maurice Maulana Situmorang, the respective minority shareholders of SKMA and SBS. The acquisition will be funded from existing cash resources and the purchase price equates to US$12,500 per Group-owned planted hectare. It is expected that the acquisition will be earnings enhancing for shareholders. Following the transaction, the Group will continue to have a strong, net cash, balance sheet, enabling it to continue to review opportunities for further growth.

As a responsible producer, and consistent with its approach to other acquisitions, the Group will work to include the acquired area as part of its registration with the Roundtable on Sustainable Palm Oil ("RSPO") in line with its commitment to continue increasing the proportion of its output that is certifiably sustainable.

M.P. Evans chairman, Peter Hadsley-Chaplin, commented: "Adding the planted areas at SKMA and SBS will bring the total Group-managed area at Bumi Mas to almost 12,000 hectares, enabling the Group to make a significant difference to the profitable utilisation of the on-site mill. This is another step forward in the Group's growth strategy, after which it will manage almost 70,000 planted hectares across its Indonesian projects."

This announcement contains information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Enquiries:

M.P. Evans Group PLC

Telephone: +44 (0) 1892 516333

Peter Hadsley-Chaplin, chairman Matthew Coulson, chief executive Luke Shaw, chief financial officer

 

Cavendish Capital Markets (Nomad and broker)

Telephone: +44 (0) 20 7220 0500

Matt Goode, George Lawson (Corporate finance)

Tim Redfern, Harriet Ward (ECM)

 

Hudson Sandler

Telephone: +44 (0) 20 7796 4133

Charlie Jack, Francis Kerrigan, Francesca Rosser

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQGPUWCCUPAUBQ
Date   Source Headline
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:30 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
26th May 20262:42 pmRNSShare Buyback Programme
20th May 202611:26 amRNSIndonesian commodity exporting
12th May 20262:52 pmRNSAGM Arrangements
1st Apr 20265:40 pmRNS2025 Annual Report
26th Mar 202610:16 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results 2025
5th Mar 20267:00 amRNSNotice of Results
23rd Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Jan 20267:00 amRNS2025 Crop and production
16th Jan 20261:05 pmRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSDirector/PDMR Shareholding
18th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 202512:58 pmRNSPublication of 2024 ESG report
2nd Dec 20251:14 pmRNSCompany update
1st Dec 20257:00 amRNSAppointment of joint broker
10th Nov 20257:00 amRNSStrong pricing during second half of 2025
28th Oct 20255:33 pmRNSHolding(s) in Company
22nd Sep 20253:26 pmRNSAIM Rule 20
15th Sep 20257:00 amRNSHalf-year Report
27th Aug 20257:00 amRNSNotice of interim results & investor presentation
29th Jul 20257:00 amRNSPublication of TCFD report
24th Jul 20257:00 amRNS2025 H1 crop and production
14th Jul 202510:07 amRNSAcquisition
7th Jul 20254:54 pmRNSDirector/PDMR Shareholding
30th Jun 20254:30 pmRNSTotal Voting Rights
25th Jun 202511:18 amRNSIssue of Equity
18th Jun 20257:00 amRNSShare buyback programme
13th Jun 20251:45 pmRNSResult of AGM
13th Jun 20257:00 amRNSAGM Statement
12th Jun 20254:50 pmRNSAppointment to board roles
5th Jun 20257:00 amRNSAGM update
14th May 20257:00 amRNSDirectorate Change
22nd Apr 20255:33 pmRNSDirector/PDMR Shareholding
16th Apr 202511:00 amRNSAcquisition
31st Mar 20254:02 pmRNSPosting of Annual Report
25th Mar 20257:00 amRNSFinal Results
21st Mar 20257:00 amRNSDirector retirement
5th Mar 20257:00 amRNSNotice of Results and investor presentation
20th Jan 20253:05 pmRNSDirector/PDMR Shareholding
20th Jan 20257:00 amRNSCrop and production
2nd Jan 202511:31 amRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.